Gut microbial disruption in critically ill patients with COVID-19 associated pulmonary aspergillosis
D. Schult, C. Maurer, P. Koyumdzhieva, S. Reitmeier, M. Middelhoff, S. Rasch, M. List, K.-P. Janssen, K. Steiger, U. Protzer, R. M. Schmid, K. Neuhaus, D. Haller, M. Quante, T. Lahmer
This study investigates the gut and bronchial microbiota in critically ill COVID-19 patients with and without CAPA, finding reduced gut diversity and increased Staphylococcus epidermidis in CAPA patients.
bioRxiv · Oct 8, 2022Microbiology